Here are 42 quick answers and the frequently asked questions from 77 guides: 497 questions in all. Each quick answer links to the guide or tool that covers it in depth; the guide questions take you straight to their answer, with the rest of the context and the sources.

Can’t find what you are looking for? Try the site search.

GLP-1201 questions

Quick answers

21 questions
  • What share of people lose at least 10% of their body weight?

    In the trials, most people, but not everyone. In STEP 1, 66.1% of people on semaglutide 2.4 mg lost at least 10% (12.0% on placebo) over 68 weeks, according to the US Wegovy label; on tirzepatide 15 mg in SURMOUNT-1 it was 83.5% over 72 weeks, according to the Zepbound label. Participants were selected and got diet and activity counseling, and trials can’t be compared with each other. The full table by threshold is in how much weight people lose on GLP-1 medications.

  • Do you have to take it for life?

    How long you stay on it is a decision you make with your prescriber; what I can share is what the data show. When people stop, appetite comes back and, on average, much of the weight does too: in the STEP 1 extension, people who had lost an average of 17.3% on semaglutide regained about two-thirds of it over the following year. The authors conclude that obesity is a chronic disease and that keeping the improvements appears to require ongoing treatment. I cover it in what happens when you stop, and the doctor-visit checklist includes this question.

  • Is vomiting normal? When is it a warning sign?

    Vomiting is common early on and around dose increases: the US labels report it in 24% on Wegovy versus 6% on placebo, and 8% to 13% on Zepbound versus 2%. Call your prescriber if you can’t keep food or liquids down, vomit 3 or more times in a day or go 8 hours or more without urinating, as MedlinePlus advises. Severe stomach pain that won’t go away means calling your prescriber right away. What to eat on those days, and the other warning signs, are in nausea on GLP-1 medications.

  • Can it cause pancreatitis or gallbladder problems?

    Both are rare, but the symptoms are worth knowing. In the weight-management trials, the Wegovy label reports 4 confirmed cases of acute pancreatitis on Wegovy (0.2 per 100 patient-years) versus 1 on placebo, and the Zepbound label 0.2% on Zepbound versus 0.2% on placebo; all four US labels also warn about gallbladder disease. The Medication Guides say that severe pain in the stomach area that won’t go away, sometimes felt through to the back, means calling your healthcare provider right away. More in nausea on GLP-1 medications and Ozempic vs Mounjaro; if you’ve had pancreatitis or gallbladder problems, tell your prescriber.

  • Can it affect your eyesight?

    All four US labels warn about diabetic retinopathy complications in people with type 2 diabetes. The EU prescribing information for semaglutide also says to stop it if NAION (damage to the optic nerve) is confirmed after a sudden loss of vision; the current US labels don’t include that warning. If you suddenly lose vision, contact your doctor or go to the emergency room the same day. I cover it in what happens when you stop and Ozempic vs Mounjaro.

  • Can it cause low blood sugar if I don’t have diabetes?

    The insulin effect of these drugs depends on glucose: they boost insulin only when blood sugar is high. That’s why the US labels flag hypoglycemia (low blood sugar) mainly when these drugs are used with insulin or an insulin secretagogue, such as a sulfonylurea. If you take one of those, or notice symptoms of low blood sugar, talk to your prescriber. I explain it in what GLP-1 medications are.

  • Do we know the long-term effects?

    The family has been in use for more than 20 years: the FDA approved the first one, exenatide, on April 28, 2005, for type 2 diabetes. For semaglutide in people without diabetes, the SELECT trial followed 17,604 adults with existing cardiovascular disease for an average of 39.8 months: heart attack, stroke or cardiovascular death occurred in 6.5% on semaglutide 2.4 mg and 8.0% on placebo, and 16.6% stopped semaglutide because of side effects (8.2% on placebo). Tirzepatide was first approved in 2022, so there are fewer years of data. More in what GLP-1 medications are; if a specific effect worries you, talk to your prescriber.

  • Is it normal to feel dizzy or have low blood pressure?

    It can happen. The Wegovy label reports dizziness in 8% versus 4% on placebo, and low-blood-pressure reactions in 1.3% versus 0.4%, and the Zepbound label dizziness in 4% to 5% versus 2%, and hypotension in 1.6% versus 0.1%, partly alongside digestive side effects and fluid loss. Sip fluids through the day, and get same-day care if you feel dizzy when you stand up and it doesn’t go away, as the UK’s NHS advises. If you take blood pressure medication, tell your prescriber; more in hydration on GLP-1 medications.

  • What should I do if I miss a dose?

    That’s a decision for your prescriber, because it depends on the medication and on you; I don’t give dosing instructions here. Get the answer ahead of time with the doctor-visit checklist.

  • When should my dose go up, and what is the maintenance dose?

    That’s your prescriber’s call, based on how you tolerate it and how you’re doing; I don’t give dosing advice here. Bring it to your next visit with the doctor-visit checklist.

  • Can I use it if I’m trying to get pregnant, pregnant or breastfeeding?

    That’s a decision for your prescriber, and worth raising well ahead of time if you’re planning a pregnancy. The doctor-visit checklist covers pregnancy, breastfeeding and birth control.

  • Does it interact with metformin, birth control pills, antidepressants or other medications?

    Possible interactions are for your prescriber to assess, with the full list of what you take; don’t change or stop any medication on your own. Bring that list along with the doctor-visit checklist.

  • Do I need to stop it before surgery, an endoscopy or a colonoscopy?

    Your prescriber and the team doing the procedure decide that, so tell them early that you take it. The doctor-visit checklist helps you remember.

  • Why do I feel so cold on Zepbound, Wegovy or Ozempic?

    Feeling cold isn’t listed as a side effect on the US Wegovy or Zepbound labels, but it comes up a lot in forums, including during maintenance, and I haven’t found studies that explain it. What you can check is whether you’re eating too little: the 2025 joint advisory warns that below about 1,200 kcal a day for women or 1,800 kcal for men, the risk of falling short on vitamins and minerals goes up. Regular small meals with protein and enough fluids help either way; there are ideas in what to eat on GLP-1 medications. If the cold is intense, comes with a lot of tiredness or doesn’t get better, tell your doctor, who can decide whether you need a blood test.

  • Is it normal to get headaches in the first weeks?

    It can happen. Headache is listed as a side effect on the US Wegovy label, and the EU prescribing information rates it very common (more than 1 in 10 people), seen mostly while the dose is being increased; the Zepbound label doesn’t list it for its weight-management trials. Not drinking enough can also give you a headache, and the UK’s NHS counts it among the signs of dehydration, so sip fluids through the day, as I explain in hydration on GLP-1 medications. If it’s very severe, comes on suddenly, comes with changes in your vision, or vomiting keeps you from holding fluids down, call your doctor the same day.

  • Are muscle, neck or jaw aches normal after a dose?

    Muscle aches aren’t listed as side effects on the US Wegovy or Zepbound labels; the EU prescribing information for Wegovy and Mounjaro does list injection-site reactions as common (up to 1 in 10 people). Some people in forums describe neck, jaw or body aches after their first dose, but I haven’t found studies that describe them. In the meantime, cover the basics, enough fluids and protein spread across small meals, as I explain in hydration on GLP-1 medications and protein and muscle on GLP-1 medications. Write it down in the symptom diary and tell your doctor, without waiting for your next visit if the pain is severe or comes with fever, weakness or trouble breathing.

  • Can Zepbound, Wegovy or Ozempic cause insomnia?

    Insomnia isn’t listed on the US Wegovy or Zepbound labels; the EU prescribing information for Saxenda (liraglutide, an older GLP-1 medication) does list it as common, mostly in the first 3 months. At night, reflux or nausea can get in the way, and the habits MedlinePlus sums up help: regular hours, no caffeine or alcohol in the evening and no heavy meals in the 2 hours before bed. I cover them in sleep, stress and appetite, and nighttime reflux in acid reflux on GLP-1 medications. If insomnia has become a problem, talk to your doctor; I don’t cover sleeping pills or sleep supplements here.

  • I don’t enjoy going out anymore: is it anhedonia from the treatment?

    Anhedonia, losing interest or pleasure in things you used to enjoy, isn’t listed as a side effect on the US Wegovy or Zepbound labels, although it comes up in forums. If many of your plans revolved around food and drinks, it makes sense that they feel different with less appetite; there are ideas for those situations in eating out on GLP-1 medications. If the loss of interest or low mood lasts for weeks or makes it hard to function at home or at work, tell your doctor, who can assess whether it’s related to the treatment. If you have thoughts of harming yourself, get help right away: call or text 988 in the US, or call your local emergency number.

  • Is my brain fog from the drug or from eating too little?

    “Brain fog” isn’t listed as a side effect on the US Wegovy or Zepbound labels, although it comes up in forums, and I haven’t found studies that separate the drug’s effect from the effect of eating little. What the labels do list is fatigue, in 11% on Wegovy versus 5% on placebo, and 5% to 7% on Zepbound versus 3%, and the UK’s NHS counts tiredness and dizziness among the signs of dehydration. Check whether you’re getting regular meals with protein and enough fluids with what to eat on GLP-1 medications and hydration on GLP-1 medications, and note how you eat and sleep in the symptom diary. Tell your doctor, and don’t wait if you feel confused and use insulin or a sulfonylurea, because it could be low blood sugar.

  • Can it cause anxiety or panic attacks?

    In adults, anxiety isn’t listed as a side effect on the US Wegovy or Zepbound labels, although some people in forums say they’ve felt it since starting. The EU prescribing information does list a faster heart rate, common on Mounjaro and uncommon on Wegovy, which can feel like your heart is racing. MedlinePlus suggests seeing your doctor if stress is overwhelming you, with feelings of panic, fears you can’t control or trouble functioning at home or at work; what helps with sleep and stress is in sleep, stress and appetite. Talk to your doctor without changing your treatment on your own, and call 911 if you have chest pain, feel short of breath or faint.

  • Do Zepbound, Wegovy or Ozempic help with lipedema or lymphedema?

    We don’t know. The trials behind their use for weight, such as STEP 1 with semaglutide and SURMOUNT-1 with tirzepatide, enrolled adults with obesity or overweight and measured total body weight, with no separate results for lipedema (a buildup of fat, often painful, mostly in the legs) or lymphedema (swelling from a buildup of lymph fluid). I haven’t found controlled trials in either condition, so what you read in forums is individual experience. If you have lipedema or lymphedema, bring it up with your prescriber and the specialist who follows you.

Liraglutide (Saxenda, Victoza): The Complete Guide

7 questions

Semaglutide (Ozempic, Wegovy, Rybelsus): The Complete Guide

9 questions

Tirzepatide (Mounjaro, Zepbound): The Complete Guide

10 questions

What Are GLP-1 Medications? How They Work and Which Ones Exist

11 questions

Amycretin (Zenagamtide): What It Is, What Early Trials Showed and Where It Stands

4 questions

CagriSema: What It Is, What the REDEFINE Trials Showed and When It Could Be Approved

4 questions

Ozempic, Wegovy and Zepbound Pens and Needles: How to Dispose of Them and How to Travel With Them

5 questions

GLP-1 Medications and Menopause: Weight, Muscle, Bone, Hormone Therapy and What the Trials Show

5 questions

Reaching Your Goal Weight on Wegovy, Zepbound or Ozempic: What Maintenance Looks Like

3 questions

GLP-1 Patches: What's Actually in Them and What the FDA and FTC Say

5 questions

GLP-1 Pills: Rybelsus, Ozempic Tablets, the Wegovy Pill and Orforglipron (Foundayo)

7 questions

Redness, Itching or Bruising Where You Inject Ozempic, Wegovy, Zepbound or Mounjaro: What the Labels Say

5 questions

Maridebart Cafraglutide (MariTide): What It Is, Phase 2 Results and Trial Status

4 questions

Mounjaro and Zepbound (Tirzepatide) Side Effects by Dose

7 questions

Period Changes on Ozempic, Wegovy, Mounjaro or Zepbound: What's Known and What the Labels Say

7 questions

Retatrutide: What It Is, Where the Trials Stand and Why It Isn't Sold (2026)

5 questions

Side Effects of Ozempic, Wegovy, Zepbound and Mounjaro, Week by Week

14 questions

Still Hungry on Ozempic or Mounjaro: Causes and What to Check

6 questions

Survodutide: What It Is, What Phase 3 Showed and When It Could Be Approved

4 questions

The Wegovy Pill: Side Effects, OASIS 4 Results and How It Compares With the Shot

6 questions

Zepbound for Sleep Apnea: What SURMOUNT-OSA Showed and What Is Approved

6 questions

Zepbound vs Wegovy: Differences From the FDA Labels and the Trials

4 questions

Generic Semaglutide: When Patents Expire and What's Approved (2026)

5 questions

GLP-1 Generic and Brand Names: Semaglutide, Tirzepatide, Liraglutide

6 questions

Mounjaro vs Zepbound: Same Drug, Different Labels (and Prices)

6 questions

Ozempic vs Wegovy: What's Different When It's the Same Molecule

7 questions

How Much Weight Do People Lose on Ozempic, Wegovy or Zepbound? Trial Data

6 questions

Ozempic vs Mounjaro (and Zepbound): Real Differences From the Trials and Labels

7 questions

BMI: What It Measures, What It Misses and Why Drug Labels Use It

5 questions

Eating on GLP-1132 questions

Quick answers

9 questions
  • What should I eat when I feel nauseous?

    Small amounts, often: the 2025 joint advisory on nutrition and GLP-1 therapy suggests a small breakfast, then something small every 3 to 4 hours. Choose bland, cold or mild-smelling, low-fat foods such as toast, yogurt, baked chicken or fish, potatoes or rice, and sip fluids instead of drinking a big glass with your plate. To make those small amounts count, 60 g (2.1 oz) of tuna with 150 g (about 1 cup) of rice adds up to 19.3 g of protein, according to USDA FoodData Central. More ideas in nausea on GLP-1 medications: what to eat.

  • Which foods make nausea worse?

    Mostly large or very fatty meals and fried food, because these medications slow down how fast your stomach empties. The National Cancer Institute suggests skipping very sweet or spicy food if it bothers you; the 2025 advisory adds that alcohol can make nausea worse, and MedlinePlus suggests avoiding caffeine and carbonated drinks. If smells get to you, cold food and not cooking strong-smelling dishes usually help. Nothing has to be off-limits, just try small amounts; details in nausea on GLP-1 medications: what to eat.

  • What should I eat when I have diarrhea?

    You don’t need to fast: the NIDDK says most experts don’t recommend a restricted diet beyond avoiding a few foods. Small, mild meals work well (white rice, pasta, baked potatoes, baked chicken or fish, cooked eggs), plus something salty and something with potassium, such as soup or a banana. For a few days, cut back on fried food, alcohol, caffeine, juice and “sugar-free” gum, and drink more than usual. I explain it, with a sample day and the warning signs, in diarrhea on GLP-1 medications: what to eat.

  • How much fiber do I need, and how do I add it without bloating?

    The National Academies recommend 25 g of fiber a day for women and 38 g for men up to age 50, and 21 g and 30 g after 50. Small portions make that hard, so add it gradually and with enough fluids: a sudden jump brings gas and bloating. Beans bring the most; 150 g (a scant cup) of cooked black beans has 13.1 g, according to USDA FoodData Central. Tally your day with the fiber calculator, and if you’re already constipated, read constipation on GLP-1 medications.

  • Is there an official Ozempic diet or a printable meal plan?

    There’s no official diet: the US weight-management labels cover these drugs alongside a reduced-calorie diet and more physical activity, without a set menu. With a small appetite, small meals with protein at each one and fiber increased gradually tend to work best. There’s a 7-day meal plan built from the site’s recipes, at 1,235 to 1,338 kcal and 73 to 98 g of protein a day according to USDA FoodData Central, and the weekly menu planner builds another printable week from your protein target.

  • How do I handle meals and my pen when I travel?

    Pack something with protein so you don’t go hours without eating: a small can of tuna in water (60 g, 2 oz drained) has 15.3 g, and 30 g (1 oz) of dry-roasted peanuts, 7.3 g, according to USDA FoodData Central. Across time zones, favor small, regular meals, and in the heat, drink more in sips. The storage section of each label says how long the medication can stay out of the fridge, for example up to 21 days in total, at up to 86 °F, for a Zepbound single-dose pen or vial; if a trip overlaps your dose day, ask your pharmacist or prescriber before you leave. More in eating out on GLP-1 medications.

  • Why do I burp so much on Ozempic, Wegovy or Zepbound?

    Burping appears on all four US labels, for example in 7% on Wegovy versus under 1% on placebo, and 4% to 5% on Zepbound versus 1%, and none of them explains why. The NIDDK says you swallow more air when you chew gum, suck on hard candy, drink fizzy drinks and eat or drink too fast, and suggests avoiding those, and not drinking through a straw. As for the “sulfur burps” that smell like rotten eggs, I haven’t found any studies. More in acid reflux on GLP-1 medications.

  • Why do I have so much gas and bloating?

    Bloating is a listed side effect: in the weight-management trials on the US labels, it affected 7% on Wegovy versus 5% on placebo, and 3% to 4% on Zepbound versus 2%. The labels don’t explain why, but the 2025 advisory links bloating to the slower stomach emptying these medications cause. Adding fiber and beans gradually, eating slowly and skipping gum and fizzy drinks usually help; details in plant protein on GLP-1 medications and acid reflux on GLP-1 medications. If bloating comes with severe pain or vomiting, or you can’t pass gas or have a bowel movement, get medical care the same day.

  • Do I need a registered dietitian, or can I manage on my own?

    It isn’t required, but there are situations where a registered dietitian helps a lot. For example, if you’ve been eating very little for weeks, because the 2025 joint advisory warns that below about 1,200 kcal a day for women or 1,800 kcal for men, the risk of falling short on vitamins and minerals goes up; also if you eat vegetarian or vegan, have kidney disease or have had an eating disorder, which the advisory recommends screening for. To get started on your own, there’s what to eat on GLP-1 medications and the protein calculator. Ask your doctor whether a referral makes sense and whether your insurance covers it, with the doctor-visit checklist.

What to Eat on GLP-1 Medications (Ozempic, Wegovy, Zepbound): A Phase-by-Phase Guide

6 questions

Food Tastes Different on Ozempic, Wegovy or Zepbound: Taste, Smell, Coffee and Meat Aversions

4 questions

Ozempic or Mounjaro With Type 2 Diabetes: What to Eat and What Changes

4 questions

Batch Cooking With a Small Appetite: Cook Once, Eat Well All Week

4 questions

Do I Have to Count Calories on Ozempic, Wegovy or Zepbound? What the Trials Did and What to Watch Instead

5 questions

The Harvard Healthy Eating Plate on Ozempic or Zepbound: How to Adapt It

5 questions

Thanksgiving, Christmas and New Year on Ozempic, Wegovy or Zepbound: How to Eat, Drink and Enjoy the Holidays

4 questions

How to Read a Nutrition Facts Label When You Eat Less (Plus EU and Mexican Labels)

6 questions

Sweet Cravings on Ozempic or Mounjaro: Why They Linger and What Helps

5 questions

Vitamins and Minerals When You Eat Very Little on Ozempic, Zepbound or Mounjaro: What to Watch

5 questions

Acid Reflux and Heartburn on GLP-1 Medications: Why It Happens and What to Eat

5 questions

Constipation on Ozempic, Wegovy or Zepbound: Why It Happens and What Helps

5 questions

Diarrhea on Ozempic, Wegovy or Zepbound: What to Eat and Drink

3 questions

Eating Out on Ozempic, Wegovy or Zepbound: A Practical Restaurant Guide

6 questions

Filling Snacks on Ozempic, Wegovy or Zepbound: 25 Ideas With Protein or Fiber

6 questions

Foods to Avoid on Ozempic, Wegovy or Zepbound: What the Label Says

14 questions

7-Day Meal Plan for Ozempic, Wegovy or Zepbound When Your Appetite Is Small

6 questions

12 High-Protein Breakfasts for Days When You Have No Appetite

6 questions

10 High-Protein Shakes Without Protein Powder

6 questions

Hydration on Ozempic, Wegovy or Zepbound: How Much Water and Warning Signs

7 questions

Nausea on Ozempic, Wegovy or Zepbound: What to Eat and What to Avoid

5 questions

Plant Protein on GLP-1 Medications: How to Reach Your Target Without Meat

6 questions

Satiety68 questions

Quick answers

2 questions
  • Do GLP-1 medications stop binge eating or emotional eating?

    They reduce hunger: according to the EU prescribing information for Wegovy, semaglutide reduces hunger and the frequency and intensity of cravings. But binge-eating disorder isn’t among their approved uses: it’s a mental health condition with its own treatments. Eating large amounts when you’re not hungry, in secret or with guilt are symptoms MedlinePlus lists for that disorder; if you see yourself there, talk to your doctor. The appetite effect is covered in the science of satiety, and what’s known about “emotional hunger” in sleep, stress and appetite.

  • How do I learn to recognize hunger and fullness again?

    It helps to separate two processes, following a 2010 review by Blundell’s group: satiation makes you stop eating, and satiety sets how long it takes for hunger to come back. Eating slowly may help: in Robinson’s meta-analysis, eating more slowly was linked to eating less at that meal, although results varied a lot between studies. Protein, water-rich foods and good sleep help too. I explain it in the science of satiety.

The Most Filling Foods, According to the Science (With Per-Serving Data)

6 questions

The Science of Satiety: Hunger, Hormones, and Why You Don't Feel Full

7 questions

Food Noise: What It Is, What the Science Says and What GLP-1 Drugs Do

5 questions

Glucomannan (Konjac) for Weight Loss: What the Evidence and Regulators Say

5 questions

Hunger and Fullness Scale From 1 to 10: How to Use It on Ozempic, Wegovy, Mounjaro or Zepbound

3 questions

Soluble vs. Insoluble Fiber: Differences, Foods, and Fullness

6 questions

Always Hungry? Causes of Constant Hunger and What Helps

6 questions

Early Satiety: Why You Feel Full After a Few Bites (and What to Eat)

5 questions

How Much Protein Is in an Egg (and 24 More Foods), per Serving

5 questions

Loss of Appetite: Common Causes and How to Eat Well When You're Not Hungry

7 questions

15 Filling Lunches, Dinners, and Snacks That Keep You Full on Fewer Calories

5 questions

Sleep, Stress, and Appetite: Why You Eat More After a Bad Night

6 questions

Lifestyle82 questions

Quick answers

6 questions
  • Is walking enough, or do I need strength training?

    Walking counts, but strength training has more support for keeping muscle. In the Villareal trial (2017), with 160 older adults with obesity who were dieting, without GLP-1 drugs, lean mass fell 5% with aerobic exercise alone, 3% with aerobic plus strength training and 2% with strength training alone. The WHO recommends strength training on 2 or more days a week and 150 to 300 minutes a week of moderate aerobic activity. More in protein and muscle on GLP-1 medications.

  • Is using a GLP-1 medication “cheating”?

    No. When you lose weight, your body pushes to regain it: in a 2011 study, a year after weight loss, ghrelin and hunger were still higher and several fullness signals still lower. The authors of the STEP 1 extension conclude that obesity is a chronic disease. It’s the same logic as with high blood pressure: the treatment works while you take it. If people ask, your treatment is health information and you decide who hears about it; there are answers that don’t open a debate in eating out on GLP-1 medications, and the biology is in the science of satiety.

  • How can I track progress besides the scale?

    Your waist is the simplest measure: stand up, place the tape just above your hipbones and measure right after you breathe out. According to the NHLBI, more than 35 inches for women and 40 inches for men raises the risk of heart disease and type 2 diabetes. Weight is only one part of health: blood pressure, blood sugar, strength and sleep count too. I explain it in what BMI measures and misses; if weighing yourself makes you anxious, tell your doctor.

  • Can it help you drink less alcohol?

    There’s early evidence, not an approved use. In a phase 2 trial of 48 adults with alcohol use disorder, 9 weeks of semaglutide reduced cravings; the authors present it as a starting point for larger trials. If you’re worried about your drinking, talk to your doctor. The context is in what GLP-1 medications are, and the trial details in its study summary.

  • My partner snacks all evening at home: how do I handle it?

    I haven’t found studies on this exact situation, so here’s the practical side. It helps to talk about it without asking them to eat the way you do: agree on a cupboard or shelf for their snacks, and keep your own, with protein or fiber, within reach for when you’re truly hungry; there are ideas in filling snacks on GLP-1 medications. If the urge shows up mostly when you’re tired or stressed, what’s known about “emotional hunger” is in sleep, stress and appetite. If food at home has become a source of tension or distress, talk to your doctor or a registered dietitian.

  • Do breasts change with weight loss, and does exercise help?

    The labels don’t list breast changes, but breasts contain a good deal of fat and, with weight loss of any kind, they can lose volume and firmness, just as the face can. Strength training works the chest muscle underneath and helps you keep muscle while losing weight, but I haven’t found trials showing that it changes breast volume or shape. What has support for your body and skin is in Ozempic face and protein and muscle on GLP-1 medications. If you notice a lump, changes in the skin or nipple, or discharge, tell your doctor, whatever the cause.

Alcohol on Ozempic, Wegovy, Zepbound or Mounjaro: What the Evidence Says

5 questions

Clothes and Sizes While Losing Weight on Ozempic, Wegovy or Zepbound: When to Buy and How Not to Overspend

4 questions

Strength Training on Ozempic, Wegovy or Zepbound: How to Start

7 questions

Bioimpedance Scale or DEXA: How to Tell If You're Losing Fat or Muscle

6 questions

“Ideal Weight”: Why There's No Single Number and What to Look at Instead

5 questions

Loose Skin After Weight Loss on Ozempic, Wegovy or Zepbound: What's Normal, What Helps and What Doesn't

5 questions

Should You Tell People You Take Ozempic or Zepbound? What to Say at Work, at Home and With Friends

6 questions

Weight-Loss Plateau on Ozempic, Wegovy or Zepbound: Why It Happens and What the Evidence Says

7 questions

Hair Loss on Ozempic, Wegovy, Zepbound or Mounjaro: Why It Happens and What Helps

7 questions

Ozempic Face: What It Is, Why It Happens, and What the Evidence Says

10 questions

Protein and Muscle on GLP-1 Medications: How Much You Need and How to Keep It

7 questions

What Happens When You Stop Ozempic, Wegovy or Zepbound: Weight Regain, Explained

7 questions

News14 questions

Quick answers

4 questions
  • What is retatrutide, and when will it be available?

    It’s a drug in development that activates three receptors: GIP, GLP-1 and glucagon. In its phase 2 trial of 338 adults without diabetes, weight fell 24.2% on 12 mg versus 2.1% on placebo over 48 weeks; phase 3 obesity results have only been announced in press releases. It isn’t approved anywhere, and Eli Lilly plans to apply for US approval in 2027. More in what GLP-1 medications are and how much weight people lose.

  • What is CagriSema?

    It’s a weekly combination in development of semaglutide and cagrilintide, an analog of amylin, another hormone that reinforces fullness. In REDEFINE 1, with 3,417 adults with obesity or overweight and no diabetes, weight fell 20.4% versus 3.0% on placebo over 68 weeks. Novo Nordisk applied for FDA approval in December 2025, and it isn’t approved anywhere yet. I place it alongside the rest of the family in what GLP-1 medications are.

  • Is compounded semaglutide or tirzepatide the same as the brand-name drugs?

    No: compounded versions aren’t FDA-approved, and the FDA explains that it doesn’t review them for safety, effectiveness or quality before they’re sold. As of May 31, 2026, it had received 990 adverse event reports for compounded semaglutide and more than 730 for compounded tirzepatide, some linked to dosing errors. It also warns about fraudulent products labeled as compounded semaglutide or tirzepatide. More in what GLP-1 medications are.

  • Do “GLP-1” patches, drops or supplements work like Ozempic?

    They aren’t GLP-1 medications: they haven’t been approved or evaluated for safety and effectiveness. In December 2024, the FDA sent a warning letter to a company selling weight-loss drops promoted with “The Science of GLP-1” and an “FDA APPROVED” badge, and found they were unapproved new drugs with misleading labeling. Semaglutide resists breakdown and has a half-life of about a week, which no food reproduces. More in what GLP-1 medications are and the science of satiety.

"Natural Ozempic" and GLP-1 Supplements: What the Evidence Says

5 questions

Orforglipron (Foundayo): Approval Status, Trials, Side Effects and Price

5 questions